Naegis Pharmaceuticals

Canada
Sydney Forks, Nova Scotia, Canada, V5Z 1K5

Company profile

Naegis Pharmaceuticals company profile

Naegis Pharmaceuticals Inc. is a Canadian biopharmaceutical company developing novel, small molecules for the treatment of serious inflammatory diseases.Chronic inflammatory disease represents an enormous societal and economic burden, particularly in an aging population, impacting both quality and quantity of life. Naegis Pharmaceuticals Inc. is driven to discover new therapies that target underlying chronic inflammatory processes in disease. The Naegis research team seeks to design new drugs that offer safer and more effective treatment options for patients, focusing first on serious eye conditions that result in damage to the back of the eye, with a program directed towards blocking the synthesis of pro-inflammatory mediators in disease.

Business identity

Contact email
[email protected]
Phone number
604-235-1682
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2009-02-01, Month

Headquarters

Postal code
V5Z 1K5
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$350,812
Last funding
Seed / $350,812 / 2024-04-26
Last equity funding
Seed / $350,812
Investors
3

Founders and investors

Investors

Creative Destruction Lab (CDL)entrepreneurship@UBCHATCH ventures